Ernexa Therapeutics, Inc. (ERNA)
4.30
+0.14
(+3.24%)
USD |
NASDAQ |
Sep 14, 10:06
Ernexa Therapeutics Debt to Equity Ratio : 0.1091 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1091 |
| March 31, 2026 | 0.0567 |
| December 31, 2025 | 0.2041 |
| September 30, 2025 | 0.1546 |
| June 30, 2025 | 0.1334 |
| March 31, 2025 | -0.4844 |
| December 31, 2024 | 0.4021 |
| September 30, 2024 | -0.8476 |
| June 30, 2024 | -5.771 |
| March 31, 2024 | -13.91 |
| December 31, 2023 | 18.74 |
| September 30, 2023 | 11.12 |
| June 30, 2023 | 9.088 |
| March 31, 2023 | 0.1367 |
| December 31, 2022 | 0.0976 |
| September 30, 2022 | 0.3134 |
| June 30, 2022 | 0.191 |
| March 31, 2022 | 0.0674 |
| December 31, 2021 | 0.1068 |
| September 30, 2021 | 0.2476 |
| June 30, 2021 | 0.1033 |
| March 31, 2021 | -0.641 |
| December 31, 2020 | -0.2502 |
| September 30, 2020 | 6.830 |
| June 30, 2020 | 1.722 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.349 |
| December 31, 2019 | 1.194 |
| September 30, 2019 | 1.015 |
| June 30, 2019 | 1.024 |
| March 31, 2019 | 1.043 |
| December 31, 2018 | 0.5515 |
| September 30, 2018 | 0.6214 |
| June 30, 2018 | 0.7601 |
| March 31, 2018 | 0.9979 |
| December 31, 2017 | 0.9767 |
| September 30, 2017 | 0.9165 |
| June 30, 2017 | 0.9607 |
| March 31, 2017 | 1.394 |
| December 31, 2016 | 2.096 |
| September 30, 2016 | 4.691 |
| June 30, 2016 | 3.694 |
| March 31, 2016 | 2.880 |
| December 31, 2015 | 1.989 |
| September 30, 2015 | 1.413 |
| June 30, 2015 | 0.9476 |
| March 31, 2015 | 0.5698 |
| December 31, 2014 | 0.4922 |
| September 30, 2014 | 0.359 |
| June 30, 2014 | 0.2763 |
| March 31, 2014 | 0.2336 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cerenome, Inc. | 0.0081 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.315M |
| Total Liabilities (Quarterly) | 3.115M |
| Shareholders Equity (Quarterly) | 3.20M |
| Current Ratio | 2.010 |
| Net Debt Paydown Yield | 6.51% |